You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MYTX-011

Showing 1 - 25 of 122
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, NSCLC Stage IV, NSCLC Stage IIIB Trial (MYTX-011)

Not yet recruiting
  • NSCLC
  • +5 more
  • MYTX-011
  • (no location specified)
Dec 7, 2022

Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • CB-011
  • New York, New York
  • +3 more
Feb 15, 2023

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Analgesia Trial in Bellaire, San Antonio (HTX-011, Bupivacaine Hydrochloride, Ibuprofen)

Completed
  • Analgesia
  • Bellaire, Texas
  • +1 more
Oct 25, 2023

Solid Tumor, Adult Trial in Orlando, Cincinnati (ADA-011, PD(L)-1 inhibitor)

Recruiting
  • Solid Tumor, Adult
  • Orlando, Florida
  • +1 more
Jan 6, 2023

Postoperative Pain, Total Shoulder Arthroplasty, Multimodal Analgesia Trial in United States (HTX-011, Bupivacaine

Completed
  • Postoperative Pain
  • +2 more
  • Little Rock, Arkansas
  • +4 more
Oct 25, 2023

Non-muscle-invasive Bladder Cancer Trial in Myrtle Beach, Nashville (AU-011, AU-011 in Combination with Medical Laser)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • AU-011
  • AU-011 in Combination with Medical Laser
  • Myrtle Beach, South Carolina
  • +1 more
Jul 29, 2022

Primary Indeterminate Lesions or Choroidal Melanoma

Recruiting
  • Choroidal Melanoma
  • Indeterminate Lesions of Eye
    • Tucson, Arizona
    • +14 more
    Dec 7, 2022

    Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

    Terminated
    • Melanoma
    • +8 more
    • GEN-011
    • +3 more
    • Gilbert, Arizona
    • +7 more
    Jul 13, 2022

    AU-011 or Plaque Radiotherapy for Primary Indeterminate Lesions

    Recruiting
    • Choroidal Melanoma
    • Indeterminate Lesions
    • Royal Oak, Michigan
    • +6 more
    Jun 16, 2022

    Beta Thalassemia Major, Beta Thalassemia Intermedia Trial in Worldwide (SOTATERCEPT (ACE-011))

    Completed
    • Beta Thalassemia Major
    • Beta Thalassemia Intermedia
    • SOTATERCEPT (ACE-011)
    • Créteil, France
    • +14 more
    Aug 18, 2022

    Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

    Active, not recruiting
    • Malignant Melanoma
    • Angiosarcoma
    • CICS-1 (investigational device),SPM-011(investigational drug)
    • Chuo Ku, Tokyo, Japan
      National Cancer Center Hospital
    Nov 6, 2022

    Myocardial Infarction Trial in Adelaide (NP-011 (Single Ascending Dose Phase), NP-011 (Multiple Ascending Dose Phase), NP-011

    Recruiting
    • Myocardial Infarction
    • NP-011 (Single Ascending Dose Phase)
    • +2 more
    • Adelaide, South Australia, Australia
      CMAX Clinical Research Pty Ltd
    Sep 26, 2022

    Advanced Solid Cancer Trial (ORB-011)

    Not yet recruiting
    • Advanced Solid Cancer
    • (no location specified)
    Jul 14, 2023

    Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

    Active, not recruiting
    • Multiple Myeloma
    • CT-011
    • Dendritic Cell Fusion Vaccine
    • Boston, Massachusetts
    • +2 more
    Sep 5, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (Sotatercept, Placebo)

    Recruiting
    • Pulmonary Arterial Hypertension
    • Phoenix, Arizona
    • +137 more
    Jan 27, 2023

    Unresectable Angiosarcoma Trial in Tokyo (BNCT)

    Recruiting
    • Unresectable Angiosarcoma
    • BNCT
    • Tokyo, Japan
      National Cancer Center Hospital
    Nov 21, 2022

    Multiple Myeloma Trial in Atlanta, Boston (ACE-011, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Atlanta, Georgia
    • +3 more
    Oct 28, 2021

    Hepatocellular Carcinoma Trial (ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • ABSK-011 180 mg QD combined with atilizumab 1200 mg q3w
    • (no location specified)
    Jun 28, 2022

    Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma Trial in United States (AU-011, Suprachoroidal Microinjector, PDT Laser)

    Recruiting
    • Uveal Melanoma
    • +2 more
    • Tucson, Arizona
    • +21 more
    Apr 2, 2022

    Analgesia Trial in United States (HTX-011, Luer Lock Applicator, Ibuprofen)

    Completed
    • Analgesia
    • Sheffield, Alabama
    • +3 more
    Mar 11, 2022

    Post-Operative Pain, Lumbar Laminectomy Trial in United States (Bupivacaine HCI without epinephrine, HTX-011, Luer Lock

    Recruiting
    • Post-Operative Pain
    • Lumbar Laminectomy
    • Bupivacaine HCI without epinephrine
    • +2 more
    • Phoenix, Arizona
    • +11 more
    Jun 17, 2022

    Pulmonary Arterial Hypertension Trial in Worldwide (Placebo, Sotatercept)

    Completed
    • Pulmonary Arterial Hypertension
    • Phoenix, Arizona
    • +42 more
    Jan 11, 2023

    Botulism Trial (A minimum of one 5 mL serum sample (up to three per enrolled subject) will be collected.)

    Enrolling by invitation
    • Botulism
    • Blood sample collection
    • (no location specified)
    Jan 30, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023